Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Añadir filtros








Intervalo de año
1.
Experimental & Molecular Medicine ; : 71-77, 2004.
Artículo en Inglés | WPRIM | ID: wpr-190971

RESUMEN

Large doses of acetaminophen (APAP) could cause oxidative stress and tissue damage through production of reactive oxygen/nitrogen (ROS/RNS) species and quinone metabolites of APAP. Although ROS/RNS are known to modify DNA, the effect of APAP on DNA modifications has not been studied systematically. In this study, we investigate whether large doses of APAP can modify the nuclear DNA in C6 glioma cells used as a model system, because these cells contain cytochrome P450-related enzymes responsible for APAP metabolism and subsequent toxicity (Geng and Strobel, 1995). Our results revealed that APAP produced ROS and significantly elevated the 8-oxo- deoxyguanosine (8-oxodG) levels in the nucleus of C6 glioma cells in a time and concentration dependent manner. APAP significantly reduced the 8- oxodG incision activity in the nucleus by decreasing the activity and content of a DNA repair enzyme, Ogg1. These results indicate that APAP in large doses can increase the 8-oxodG level partly through significant reduction of Ogg1 DNA repair enzyme.


Asunto(s)
Animales , Humanos , Ratas , Acetaminofén/metabolismo , Analgésicos no Narcóticos/metabolismo , Línea Celular Tumoral , ADN/metabolismo , Daño del ADN , ADN Glicosilasas/metabolismo , Reparación del ADN , Desoxiguanosina/química , Glioma/metabolismo , Glutatión/metabolismo , Especies de Nitrógeno Reactivo/metabolismo , Especies Reactivas de Oxígeno/metabolismo
2.
The Korean Journal of Internal Medicine ; : 27-33, 1999.
Artículo en Inglés | WPRIM | ID: wpr-153280

RESUMEN

OBJECTIVES: The hepatotoxicity of acetaminophen is not a result of the parent compound but is mediated by its reactive metabolite N-acetyl-p-benzoquinone imine. Cytochrome P4502E1 (CYP2E1) is the principal enzyme of this biotransformation, which accounts for approximately 52% of the bioactivation in human microsomes. Recently, chlormethiazole a sedative drug, is reported to be an efficient inhibitor of CYP2E1 activity in human beings. In this study we wished to evaluate whether chlormethiazole, an inhibitor of CYP2E1, could prevent acetaminophen-induced liver injury in mice. METHODS: Acetaminophen, at doses ranging from 200 to 600 mg/kg, was injected into the peritoneum of female C57BL/6 inbred mice fasted for four hours. Chlormethiazole (60 mg/kg) or 5% dextrose water was given 30 min before or 2 h after acetaminophen. Serum aminotransferase activities, histologic index score, survival rate and hepatic malondialdehyde levels were compared. RESULTS: Pretreatment with chlormethiazole 30 min before 400 mg/kg of acetaminophen completely inhibited acetaminophen-induced liver injury (median 118.5 U/L, range 75 to 142 vs. 14,070 U/L, range 5980 to 27,680 for AST; 49 U/L, range 41 to 64 vs. 15,330 U/L, range 13,920 to 15,940 for ALT). In mice receiving chlormethiazole 2 h after acetaminophen, the mean AST and ALT levels were also less elevated, reaching only 20% of the value of acetaminophen-only group. These protective effects were confirmed histologically. Whereas more than 50% of mice died at 500 mg/kg of acetaminophen, all the mice pretreated with chlormethiazole survived at the same dose. CONCLUSION: Chlormethiazole effectively reduces acetaminophen-induced liver injury in mice. Further studies are needed to assess its role in humans.


Asunto(s)
Femenino , Humanos , Ratones , Acetaminofén/toxicidad , Acetaminofén/metabolismo , Acetaminofén/antagonistas & inhibidores , Analgésicos no Narcóticos/toxicidad , Analgésicos no Narcóticos/metabolismo , Analgésicos no Narcóticos/antagonistas & inhibidores , Animales , Clormetiazol/farmacología , Citocromo P-450 CYP2E1/antagonistas & inhibidores , Inhibidores Enzimáticos/farmacología , Hígado/metabolismo , Hígado/lesiones , Hígado/efectos de los fármacos , Ratones Endogámicos C57BL , /farmacología
3.
Acta gastroenterol. latinoam ; 25(1): 17-20, 1995. ilus, tab
Artículo en Español | LILACS | ID: lil-152633

RESUMEN

En este trabajo se estudia el efecto de la intoxicación aguda con paracetamol (P) en ratas colestáticas. Se tomaron 4 grupos de ratas: controles, controles intoxicadas con P, controles colestáticas y colestáticas intoxicadas con P. Para todos los grupos se realizaron test de bioquímica hepática e histopatología del hígado. Se concluye que las ratas colestáticas sufren menor daño hepático cuando se las somete a intoxicación con P que sus respectivos controles


Asunto(s)
Animales , Masculino , Ratas , Acetaminofén/toxicidad , Colestasis Extrahepática/inducido químicamente , Glucuronosiltransferasa/metabolismo , Acetaminofén/administración & dosificación , Acetaminofén/metabolismo , Enfermedad Aguda , Colestasis Extrahepática/enzimología , Hígado , Hígado/enzimología , Hígado/patología , Ratas Wistar
4.
Indian J Physiol Pharmacol ; 1993 Jan; 37(1): 79-81
Artículo en Inglés | IMSEAR | ID: sea-107671

RESUMEN

The effect of trichloroethylene (Trielene) anaesthesia was studied in 10 young male patients undergoing short surgical procedures. Equal number of males operated upon for the same indication under epidural anaesthesia, served as a control group. Paracetamol concentrations in saliva were measured at hourly intervals on the day before and after surgery. Paracetamol half life (t1/2) significantly decreased (from 2.5 to 0.84 h) and clearance rate (CL) significantly increased (from 8.0 to 14.0 ml/min/kg) as compared to preoperative values. The control also showed significant but smaller alterations in these parameters. Our result suggests that trielene exposure may accelerate the hepatic metabolism of paracetamol.


Asunto(s)
Acetaminofén/metabolismo , Adulto , Anestesia , Anestesia General , Semivida , Humanos , Masculino , Glándulas Salivales/efectos de los fármacos , Tricloroetileno
5.
P. R. health sci. j ; 11(3): 159-62, dic. 1992.
Artículo en Inglés | LILACS | ID: lil-176765

RESUMEN

In this study ethylcellulose was evaluated as a carrier for preparation of prolonged release acetaminophen tablets. Solid dispersions containing three levels of ethylcellulose and acetaminophen (1:3; 1:1; 3:1) were prepared by the solvent method. Also physical mixtures at the same level of ethylcellulose and acetaminophen were prepared. Systems composed of solid dispersion or physical mixture containing the equivalent weight of 50 mg acetaminophen, Emcompress as diluent and 1 per cent magnesium stearate as lubricant were compressed into tablets and tested for dissolution. The dissolution data showed that the drug release decreased as the level of ethylcellulose increased in the solid dispersion formulations. The drug release from tablets prepared with solid dispersion followed the diffusion controlled model for inert porous matrix, while the drug release from tablets prepared with physical mixture followed the first-order kinetic model


Asunto(s)
Humanos , Acetaminofén/administración & dosificación , Celulosa/análogos & derivados , Acetaminofén/metabolismo , Celulosa/administración & dosificación , Celulosa/farmacología , Preparaciones de Acción Retardada , Relación Dosis-Respuesta a Droga , Portadores de Fármacos , Composición de Medicamentos
6.
Trib. méd. (Bogotá) ; 77(10): 46-7, mayo 1988. ilus
Artículo en Español | LILACS | ID: lil-83930

RESUMEN

Son medicamentos utilizados como analgesicos y antipireticos desde los anos 50, con incremento en su uso a medida que se fueron informando graves casos de intoxicacion con acido acetilsalicilico


Asunto(s)
Acetaminofén/toxicidad , Acetaminofén/metabolismo
7.
Med. crít. venez ; 2(1): 2-6, ene.-mar. 1987. ilus
Artículo en Español | LILACS | ID: lil-45751

RESUMEN

Se realiza una revisión de las propiedades farmacológicas, mecanismo de acción y farmacocinética de el acetaminofeno. Dichos conceptos son de interés para la mejor comprensión de la intoxicación que su sobredosis produce, así como de las bases de su tratamiento y pronóstico. El mejor indicador-pronóstico del daño hepático lo constituye la determinación de la vida media de eliminación de la droga: una vida media mayor de cuatro horas se asocia con lesión hepática. Se incluye el nomograma de Rumack para la estimación de este parámetro, basada en los niveles plasmáticos de la droga


Asunto(s)
Acetaminofén/efectos adversos , Acetaminofén/metabolismo , Acetaminofén/envenenamiento , Química , Hígado/efectos de los fármacos
10.
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA